The Biosensors Market is projected to reach $43.8 billion by 2030, at a CAGR of 8.2% from 2023 to 2030. The growth of this market is driven by the emergence of nanotechnology-based biosensors in various end-use industries, the availability of advanced biosensors, and rising government initiatives. Furthermore, emerging markets in developing countries and growth potential in the wearable devices market are expected to create market growth opportunities.
However, the slow rate of commercialization and high installation and operational costs restrain the growth of this market. Also, limited adoption in hazardous sectors and the unexplored potential of biosensors pose major challenges for the players in this market.
Biosensor is an analytical device that is used to detect a biological product. Nanotechnology is playing an increasingly important role in the development of biosensors. The nanotechnology-based biosensor or nano biosensor technology is revolutionizing the health care industry as nano biosensor technology is used in the measurement of metabolites, monitoring of diabetes, forensic medicine, and homeland security. In the food and drink industry, these are used for remote sensing of water quality, determination of drug residue in food etc. For environment protection, these are used in detecting pesticides and river water contaminants like heavy metal ions and genome analysis of organisms and communications. Nanotechnology-based biosensors are made up of nanomaterials and have dimensions ranging from 1 to 100 nm. These biosensors play a vital role in sensing the mechanism of biosensing technology. Integrating devices of nanomaterials with electrical systems has led to the development of nanoelectromechanical systems. Several nanomaterials have been explored for electronic and mechanical properties to improve biological signaling and transduction mechanism, which involves converting one form of energy to another. A few such materials that are widely employed include nanotubes, nanowires, nanorods, nanoparticles, and thin films made up of crystalline matter. These sensors can be used in applications ranging from amperometric devices for the enzymatic detection of glucose to the use of quantum dots as fluorescence agents for the detection of binding and bio-conjugated nanomaterials for biomolecular detection. Thus, growing technological innovation and the proliferation of new technologies increase business complexities, boosting the growth of the biosensors market.
Click here to: Get a Free Sample Copy of this report
The Wearable Biosensors Segment to Register the Highest CAGR During the Forecast Period
Based on product, the biosensors market is segmented into wearable biosensors and non-wearable biosensors. The wearable biosensors segment is further segmented into embedded devices and non-embedded devices. The wearable biosensors segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the potential to enhance medical diagnostics and continuous health monitoring capabilities. Additionally, wearable biosensor applications aim to change centralized hospital-based care systems to home-based personal medicine and reduce healthcare costs and the duration required for diagnosis.
The Optical Biosensors Segment to Register the Highest CAGR During the Forecast Period
Based on type, the biosensors market is segmented into electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors, and other biosensor types. The optical biosensors segment is slated to register the highest CAGR during the forecast period. The growth of this segment is driven by the increasing demand for optical biosensors in examination owing to their varied analytical coverage is required. Furthermore, optical biosensors are suitable for architectural studies, fermentation monitoring, receptor-cell interactions, concentration, kinetic, and equilibrium examination.
The Agriculture Segment to Register the Highest CAGR During the Forecast Period
Based on application, the biosensors market is segmented into medical, food toxicity, agriculture, wastewater treatment, and other applications. The medical segment is further segmented into cholesterol monitoring, blood glucose testing, pregnancy testing, infectious testing, and other medical applications. The agriculture segment is projected to register the highest CAGR during the forecast. The growth of this segment is driven by the benefits offered by biosensors compared to traditional techniques used to prevent the loss of livestock and crops due to natural threats and bioterrorism.
The Healthcare Segment to Register the Highest CAGR During Forecast Period
Based on industry, the biosensors market is segmented into healthcare, food & beverages, forensic and biodefense, environmental monitoring, and other industries. The healthcare segment is projected to register the highest CAGR during the forecast period. The growth of this segment is driven by the technological advancements that create innovative products, easy to use, growing investments, funds, and grants.
Asia-Pacific to be the Fastest-growing Regional Market
Based on geography, the biosensors market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is slated to register the highest CAGR during the forecast period. The high growth rate is mainly attributed to increasing health awareness, a rising aging population, growing chronic and lifestyle illnesses, and technological progress for several home use and proper insurance coverage. Asia-Pacific countries are also expected to adopt biosensor technologies in genomics, agriculture, food safety, and the environment due to their improved economic situation and increased pollution.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by the leading market participants in the biosensors market in the last three to four years. The key players profiled in the biosensors market report are F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), DuPont de Nemours Inc. (U.S.), Siemens Healthineers AG (Germany), Ercon, Inc. (U.S.), Innovative Biosensors Inc. (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Bio-Rad Laboratories, Inc (U.S.), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (U.S.), LifeScan Inc. (U.S.), Masimo Corporation (U.S.), Nova Biomedical (U.S.), Pinnacle Technologies Inc. (U.S.), QTL Biosystems (U.S.), and TE Connectivity Corporation (Switzerland).
Scope of the report:
Biosensors Market Assessment, by Product
Biosensors Market Assessment, by Type
Biosensors Market Assessment, by Application
Biosensors Market Assessment, by Industry
Biosensors Market Assessment, by Geography
Key questions answered in the report:
The biosensors market is projected to reach $43.8 billion by 2030 at a CAGR of 8.2% during the forecast period.
In 2023, the wearable biosensors segment is expected to account for the larger share of the biosensors market.
Based on application, the biosensors market is segmented into medical, food toxicity, agriculture, wastewater treatment, and other applications. The medical segment is further segmented into cholesterol monitoring, blood glucose testing, pregnancy testing, infectious testing, and other medical applications. In 2023, the medical segment is expected to account for a larger share of the global biosensors market.
The growth of this market is driven by the emergence of nanotechnology-based biosensors in various end-use industries, the availability of advanced biosensors, and rising government initiatives. Furthermore, the emerging market in developing countries and growth potential in the wearable devices market are expected to create market growth opportunities.
The key players operating in the biosensors market are F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), DuPont de Nemours, Inc. (U.S.), Siemens Healthineers AG (Germany), Ercon, Inc. (U.S.), Innovative Biosensors Inc. (U.S.), Ascensia Diabetes Care Holdings AG (Switzerland), Bio-Rad Laboratories, Inc (U.S.), Biosensors International Group, Ltd. (Singapore), Dexcom, Inc. (U.S.), LifeScan Inc. (U.S.), Masimo Corporation (U.S.), Nova Biomedical (U.S.), Pinnacle Technologies Inc. (U.S.), QTL Biosystems (U.S.), and TE Connectivity Corporation (Switzerland).
This report provides pre & post COVID-19 market estimates.
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Assessment Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
3.1. Overview
3.2. Market Analysis, by Product
3.3. Market Analysis, by Type
3.4. Market Analysis, by Application
3.5. Market Analysis, by Industry
3.6. Market Analysis, by Geography
3.7. Competitive Analysis
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges
4.3. Case Studies
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Porter’s Five Forces Analysis
5. Biosensors Market Assessment—by Product
5.1. Overview
5.2. Wearable Biosensors
5.2.1. Embedded Devices
5.2.2. Non-embedded Devices
5.3. Non-wearable Biosensors
6. Biosensors Market Assessment—by Type
6.1. Overview
6.2. Electrochemical Biosensors
6.3. Optical Biosensors
6.4. Piezoelectric Biosensors
6.5. Thermal Biosensors
6.6. Other Biosensor Types
7. Biosensors Market Assessment—by Application
7.1. Overview
7.2. Medical
7.2.1. Cholesterol Monitoring
7.2.2. Blood Glucose Testing
7.2.3. Pregnancy Testing
7.2.4. Infectious Testing
7.2.5. Other Medical Applications
7.3. Food Toxicity
7.4. Agriculture
7.5. Wastewater Treatment
7.6. Other Applications
8. Biosensors Market Assessment—by Industry
8.1. Overview
8.2. Healthcare
8.3. Food & Beverages
8.4. Forensic and Biodefense
8.5. Environmental Monitoring
8.6. Other Industries
9. Biosensors Market Assessment—by Geography
9.1. Overview
9.2. Asia-Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Singapore
9.2.6. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.4. Europe
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Netherlands
9.4.7. Rest of Europe
9.5. Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.2.1. Market Differentiators
10.2.2. Synergy Analysis: Major Deals & Strategic Alliances
10.3. Competitive Dashboard
10.3.1. Industry Leaders
10.3.2. Market Differentiators
10.3.3. Vanguards
10.3.4. Emerging Companies
10.4. Vendor Market Positioning
10.5. Market Share Analysis (2021)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. F. Hoffmann-La Roche Ltd
11.2. Abbott Laboratories
11.3. Thermo Fisher Scientific Inc.
11.4. Danaher Corporation
11.5. DuPont de Nemours, Inc
11.6. Siemens Healthineers AG
11.7. Ercon, Inc.
11.8. Innovative Biosensors Inc.
11.9. Ascensia Diabetes Care Holdings AG
11.10. Bio-Rad Laboratories, Inc
11.11. Biosensors International Group, Ltd
11.12. Dexcom, Inc.
11.13. LifeScan Inc.
11.14. Masimo Corporation
11.15. Nova Biomedical
11.16. Pinnacle Technologies Inc.,
11.17. QTL Biosystems
11.18. TE Connectivity Corporation
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Currency Conversion Rates (2019–2022)
Table 2 Global Biosensors Market, by Product, 2021–2030 (USD Million)
Table 3 Global Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 4 Global Wearable Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Wearable Biosensors Market for Embedded Devices, by Country/Region, 2021–2030 (USD Million)
Table 6 Global Wearable Biosensors Market for Non-embedded Devices, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Non-wearable Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Biosensors Market, by Type, 2021–2030 (USD Million)
Table 9 Global Electrochemical Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Optical Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Piezoelectric Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Thermal Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Other Biosensor Types Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Biosensors Market, by Application, 2021–2030 (USD Million)
Table 15 Global Biosensors Market for Medical, by Type, 2021–2030 (USD Million)
Table 16 Global Biosensor Market for Cholesterol Monitoring, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Biosensor Market for Blood Glucose Testing, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Biosensor Market for Pregnancy Testing, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Biosensor Market for Infectious Testing, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Biosensor Market for Other Medical Applications, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Biosensors Market for Food Toxicity, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Biosensors Market for Agriculture, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Biosensors Market for Wastewater Treatment, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Biosensors Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 26 Global Biosensors Market for Healthcare, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Biosensors Market for Food & Beverages, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Biosensors Market for Forensic & Biodefense, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Biosensors Market for Environmental Monitoring, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Biosensors Market for Other Industries, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 32 Asia-Pacific: Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 33 Asia-Pacific: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 34 Asia-Pacific: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 35 Asia-Pacific: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 36 Asia-Pacific: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 37 Asia-Pacific: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 38 Asia-Pacific: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 39 China: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 40 China: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 41 China: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 42 China: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 43 China: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 44 China: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 45 Japan: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 46 Japan: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 47 Japan: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 48 Japan: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 49 Japan: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 50 Japan: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 51 India: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 52 India: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 53 India: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 54 India: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 55 India: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 56 India: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 57 Singapore: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 58 Singapore: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 59 Singapore: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 60 Singapore: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 61 Singapore: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 62 Singapore: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 63 South Korea: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 64 South Korea: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 65 South Korea: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 66 South Korea: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 67 South Korea: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 68 South Korea: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 69 Rest of Asia-Pacific: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 70 Rest of Asia-Pacific: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 71 Rest of Asia-Pacific: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 72 Rest of Asia-Pacific: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 73 Rest of Asia-Pacific: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 74 Rest of Asia-Pacific: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 75 North America: Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 76 North America: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 77 North America: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 78 North America: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 79 North America: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 80 North America: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 81 North America: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 82 U.S.: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 83 U.S.: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 84 U.S.: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 85 U.S.: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 86 U.S.: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 87 U.S.: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 88 Canada: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 89 Canada: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 90 Canada: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 91 Canada: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 92 Canada: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 93 Canada: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 94 Europe: Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 95 Europe: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 96 Europe: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 97 Europe: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 98 Europe: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 99 Europe: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 100 Europe: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 101 Germany: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 102 Germany: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 103 Germany: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 104 Germany: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 105 Germany: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 106 Germany: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 107 U.K.: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 108 U.K.: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 109 U.K.: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 110 U.K.: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 111 U.K.: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 112 U.K.: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 113 France: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 114 France: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 115 France: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 116 France: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 117 France: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 118 France: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 119 Italy: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 120 Italy: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 121 Italy: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 122 Italy: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 123 Italy: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 124 Italy: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 125 Spain: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 126 Spain: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 127 Spain: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 128 Spain: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 129 Spain: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 130 Spain: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 131 Netherlands: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 132 Netherlands: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 133 Netherlands: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 134 Netherlands: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 135 Netherlands: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 136 Netherlands: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 137 Rest of Europe: Biosensors Market, by Product, 2021–2030 (USD Million)
Table 138 Rest of Europe: Wearable Biosensors Market, by Type, 2021–2030 (USD Million)
Table 139 Rest of Europe: Biosensors Market, by Type, 2021–2030 (USD Million)
Table 140 Rest of Europe: Biosensors Market, by Application, 2021–2030 (USD Million)
Table 141 Rest of Europe: Biosensors Market for Medical, 2021–2030 (USD Million)
Table 142 Rest of Europe: Biosensors Market, by Industry, 2021–2030 (USD Million)
Table 143 Latin America: Biosensors Market, by Country/Region, 2021–2030 (USD Million)
Table 144 Middle East & Africa: Biosensors Market, by Country/Region, 2021–2030 (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approaches
Figure 7 Key Insights
Figure 8 In 2023, the Wearable Biosensors Segment is Expected to Dominate the Global Biosensors Market
Figure 9 In 2023, the Electrochemical Biosensors Segment is Expected to Dominate the Global Biosensors Market
Figure 10 In 2023, the Medical Segment is Expected to Dominate the Global Biosensors Market
Figure 11 In 2023, the Healthcare Segment is Expected to Dominate the Global Biosensors Market
Figure 12 Global Biosensors Market Value, by Country/Region (2023–2030)
Figure 13 Factors Affecting Market Growth
Figure 14 Global Biosensors Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 15 Global Biosensors Market, by Type, 2023 Vs. 2030 (USD Million)
Figure 16 Global Biosensors Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 17 Global Biosensors Market, by Industry, 2023 Vs. 2030 (USD Million)
Figure 18 Global Biosensors Market, by Country/Region, 2023 Vs. 2030 (USD Million)
Figure 19 Geographic Snapshot: Biosensors Market in Asia-Pacific
Figure 20 Geographic Snapshot: Biosensors Market in North America
Figure 21 Geographic Snapshot: Biosensors Market in Europe
Figure 22 Geographic Snapshot: Biosensors Market in Latin America
Figure 23 Geographic Snapshot: Biosensors Market in the Middle East & Africa
Figure 24 Growth Strategies Adopted by the Key Players (2020–2023)
Figure 25 Competitive Dashboard: Biosensors Market
Figure 26 Vendor Market Positioning Analysis (2020–2023)
Figure 27 Market Share Analysis: Biosensors Market (2021)
Figure 28 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 29 Abbott Laboratories: Financial Overview (2022)
Figure 30 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 31 Danaher Corporation: Financial Overview (2022)
Figure 32 DuPont de Nemours, Inc: Financial Overview (2022)
Figure 33 Siemens Healthineers AG: Financial Overview (2022)
Figure 34 Bio-Rad Laboratories, Inc: Financial Overview (2022)
Figure 35 Dexcom, Inc.: Financial Overview (2022)
Figure 36 Masimo Corporation: Financial Overview (2022)
Figure 37 TE Connectivity Corporation: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2024
Published Date: Aug-2023
